Collectively, our analyses provided evidence that restoring the expression of HOXD10 can sufficiently increase the expressions of miR-7 and IGFBP3, therefore inhibiting 5-FU resistance in CRC (Figure 6D). The gene discussed is IGFBP3; the disease is colorectal carcinoma.